The market is being driven by growing diabetes incidence due to an ageing population and an increase in obesity cases, as well as technological advancements in the field of diabetes preventive care. The introduction of technologically advanced systems has influenced the global diabetes devices market’s growth. In recent years, the need for minimally invasive devices has been met. There are a variety of items on the market that do not need a blood sample or needle-based methods to detect blood sugar levels.
The Global Diabetes Devices Market is expected to be around US$ 39.40 billion by 2028 and will grow at a CAGR of more than 6.4% in the given forecast period.
The global Diabetes Devices market is segregated on the basis of Type as Blood glucose monitoring systems, Self-monitoring blood glucose monitoring systems, Continuous glucose monitoring systems, Test strips/Test papers, Lancets/Lancing devices, Insulin delivery devices, Insulin pumps, Insulin pens, Insulin syringes and needles, and Diabetes management mobile applications. Based on End User the global Diabetes Devices market is segmented in Hospitals & specialty clinics and Self & home care.
The global Diabetes Devices market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Diabetes Devices market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Medtronic Plc, Abbott Laboratories, Arkray, Inc, B Braun Melsungen AG, Bayer Corporation, Dexcom Inc., F Hoffmann-La Roche Ag, LifeScan, Inc, Sanofi, Insulet Corporation, Novo Nordisk, Ypsomed Holding AG, Valeritas Holdings Inc., and others are among the major players in the global Diabetes Devices market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Diabetes Devices Market has been segmented as below:
Diabetes Devices Market, By Type
Diabetes Devices Market, By End User
Diabetes Devices Market, By Region
Diabetes Devices Market, By Company
The report covers:
Report Scope:
The global Diabetes Devices market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Diabetes Devices market share. Major industry players with significant revenue share include Medtronic Plc, Abbott Laboratories, Arkray, Inc, B Braun Melsungen AG, Bayer Corporation, Dexcom Inc., F Hoffmann-La Roche Ag, LifeScan, Inc, Sanofi, Insulet Corporation, Novo Nordisk, Ypsomed Holding AG, Valeritas Holdings Inc., and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
Next-generation Sequencing Market
Test and Measurement Equipment Market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Diabetes Devices market, By Type
5.1 Introduction
5.2 Blood glucose monitoring systems
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Self-monitoring blood glucose monitoring systems
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Continuous glucose monitoring systems
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Test strips/Test papers
5.5.1 Market Overview
5.5.2 Market Size and Forecast
5.6 Lancets/Lancing devices
5.6.1 Market Overview
5.6.2 Market Size and Forecast
5.7 Insulin delivery devices
5.7.1 Market Overview
5.7.2 Market Size and Forecast
5.8 Insulin pumps
5.8.1 Market Overview
5.8.2 Market Size and Forecast
5.9 Insulin pens
5.9.1 Market Overview
5.9.2 Market Size and Forecast
5.10 Insulin syringes and needles
5.10.1 Market Overview
5.10.2 Market Size and Forecast
5.11 Diabetes management mobile applications
5.11.1 Market Overview
5.11.2 Market Size and Forecast
6. Diabetes Devices market, By Type
6.1 Introduction
6.2 Hospitals & specialty clinics
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Self & home care
6.3.1 Market Overview
6.3.2 Market Size and Forecast
7. Diabetes Devices Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 North America Diabetes Devices, By Type
7.2.2 North America Diabetes Devices, By End User
7.2.3 North America Diabetes Devices, By Application
7.2.4 North America Diabetes Devices, By End-Use
7.3 Europe
7.3.1 Europe Diabetes Devices, By Type
7.3.2 Europe Diabetes Devices, By End User
7.3.3 Europe Diabetes Devices, By Application
7.3.4 Europe Diabetes Devices, By End-Use
7.4 Asia-Pacific
7.4.1 Asia-Pacific Diabetes Devices, By Type
7.4.2 Asia-Pacific Diabetes Devices, By End User
7.4.3 Asia-Pacific Diabetes Devices, By Application
7.4.4 Asia-Pacific Diabetes Devices, By End-Use
7.5 Rest of the World
7.5.1 Rest of the World Diabetes Devices, By Type
7.5.2 Rest of the World Diabetes Devices, By End User
7.5.3 Rest of the World Diabetes Devices, By Application
7.5.4 Rest of the World Diabetes Devices, By End-Use
8. Competitive Insights
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
9. Company Profiles
9.1 Medtronic Plc
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2 Abbott Laboratories
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 Arkray, Inc
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 B Braun Melsungen AG
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5 Bayer Corporation
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
9.6 Dexcom Inc.
9.6.1 Company Overview
9.6.2 Product/Service Landscape
9.6.3 Financial Overview
9.6.4 Recent Developments
9.7 F Hoffmann-La Roche Ag
9.7.1 Company Overview
9.7.2 Product/Service Landscape
9.7.3 Financial Overview
9.7.4 Recent Developments
9.8 LifeScan, Inc
9.8.1 Company Overview
9.8.2 Product/Service Landscape
9.8.3 Financial Overview
9.8.4 Recent Developments
9.9 Sanofi
9.9.1 Company Overview
9.9.2 Product/Service Landscape
9.9.3 Financial Overview
9.9.4 Recent Developments
9.10 Insulet Corporation
9.10.1 Company Overview
9.10.2 Product/Service Landscape
9.10.3 Financial Overview
9.10.4 Recent Developments
9.11 Novo Nordisk
9.11.1 Company Overview
9.11.2 Product/Service Landscape
9.11.3 Financial Overview
9.11.4 Recent Developments
9.12 Ypsomed Holding AG
9.12.1 Company Overview
9.12.2 Product/Service Landscape
9.12.3 Financial Overview
9.12.4 Recent Developments
9.13 Valeritas Holdings Inc.
9.13.1 Company Overview
9.13.2 Product/Service Landscape
9.13.3 Financial Overview
9.13.4 Recent Developments
The Diabetes Devices Market has been segmented as below:
Diabetes Devices Market, By Type
Diabetes Devices Market, By End User
Diabetes Devices Market, By Region
SUBSCRIBE TO OUR NEWSLETTERS
